Research Article
Solute Carrier Family 35 Member F2 Regulates Cisplatin Resistance and Promotes Malignant Progression of Pancreatic Cancer by Regulating RNA Binding Motif Protein 14
Figure 1
SLC35F2 is highly expressed in pancreatic cancer tissues and cell lines. (a, b) qRT-PCR detection of SLC35F2 expression in pancreatic cancer tumor tissue and nontumor tissue adjacent to the tumor; (c) qRT-PCR detection of SLC35F2 expression level in pancreatic cancer cell lines; Data are mean ± SD, , , and .
| (a) |
| (b) |
| (c) |